Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2008
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2433772C Pyrimidine matrix metalloproteinase inhibitors
10/07/2008CA2427573C Indole derivatives as pde5-inhibitors
10/07/2008CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2362831C Thioamide derivatives
10/07/2008CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
10/07/2008CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances
10/07/2008CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
10/07/2008CA2237306C Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
10/07/2008CA2209426C Human pak65
10/07/2008CA2179955C Kappa-opiate agonists for inflammatory bowel disorders
10/05/2008CA2583999A1 Characterization of a mekk binding site and uses thereof
10/02/2008WO2008118747A1 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
10/02/2008WO2008118744A1 Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
10/02/2008WO2008118468A1 Heterocyclic compounds and their uses
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008WO2008117481A1 Skin preparation for external use and food and drink
10/02/2008WO2008117230A1 Standardized bioactive herbal extracts
10/02/2008WO2008116845A1 Piperidinone carboxamide derivatives as p2x7 modulators
10/02/2008WO2008116816A1 Combination of cb2 ligand and paracetamol
10/02/2008WO2008116814A1 Pyrrole and isoindole carboxamide derivatives as p2x7 modulators
10/02/2008WO2008116620A1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/02/2008WO2008100618A3 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/02/2008WO2008082490A3 Novel jnk inhibitors
10/02/2008WO2008080015A3 Compounds and methods for kinase modulation, and indications therefor
10/02/2008WO2008071456A3 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10/02/2008WO2008064321A3 Methods of treating chronic inflammatory diseases using a gm-csf antagonist
10/02/2008US20080242839 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
10/02/2008US20080242729 Retinoid X Receptor antagonists; (2E,4E,)-(1RS,2RS)-5-[2-(3,5-di-tert-butyl-2-butoxy-phenyl)-cyclopropyl]-3-methyl-penta-2,4-dienoic acid; topical or oral administration; diseases of the skin and/or mucous membranes
10/02/2008US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders
10/02/2008US20080242710 Controlling cell adhesion, migration, activation; antiinflammatory agents; autoimmune diseases
10/02/2008US20080242705 Fluridone as an Anti-Inflammatory Agent
10/02/2008US20080242704 selectively modulate, regulate, and/or inhibit signal transduction; potent and selective c-kit, bcr-abl and Fit-3 inhibitors; diseases like cell proliferation, metabolic, allergic, cancers, degenerative, autoimmune disorders; 4-{2-[5-(Benzothiazol-2-ylammo)-2-methyl-phenylamino]-oxazol-5-yl}-benzonitrile
10/02/2008US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
10/02/2008US20080242670 Anti-Inflammatory Agents
10/02/2008US20080242668 Neurodegenerative, inflammatory disorders, pain, drug abuse; useful as diagnostic tools or monitoring agents such as for neuroimaging, labelling; nicotinic and/or monoamine receptors modulators; 2,2'-Bis-((+-)-1-aza-bicyclo[2.2.2]oct-3-yloxy)-[5,5']-bithiazolyl; cholinergic ligands
10/02/2008US20080242661 Novel compounds useful for the treatment of degenerative & inflammatory diseases
10/02/2008US20080242655 Aza-indolyl compounds and methods of use
10/02/2008US20080242651 3-(2-cyclopentyl-2-phenyl-2-hydroxyacetoxy)-1-(carboxymethyl)-1-methylpyrrolidinium inner salt; muscarinic receptor antagonist; chronic obstructive pulmonary disease or asthma; synergistic mixture with antiinflammatory corticosteroid, betamimetic agent or antiallergic agent
10/02/2008US20080242643 4-[({[4,5-bis(nitrooxy)pentyl]oxy}carbonyl)oxy]-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoic acid; antiinflammatory, analgesic agent; rheumatic diseases, influenza, common cold, pain, dysmenorrhea, headache, neuralgia, synovitis, arthritis, osteoarthritis, cardiovascular disorders, anticoagulants
10/02/2008US20080242634 Treatment for neuropathic pain due to spinal cord injury
10/02/2008US20080242632 Targets two or more Dna sequence ; anticancer agents, therapy for infections, antiinflammatory agents, autoimmune diseases; respiratory system disorders; liver disorders
10/02/2008US20080242628 In vivo
10/02/2008US20080242605 Prevent binding of formyl methionine-leucine-phenylalanine and, or protein to granulocytes; antiinflammatory agents; viricides; HIV infections
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders
10/02/2008US20080241884 Fused Protein Composition
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241279 Materials and methods of using calcium for reduction of inflammation
10/02/2008US20080241251 Method of Producing Microparticles
10/02/2008US20080241239 Pharmaceutical Tablets Having a Separation Mark Positioned on the Side of Said Tablets
10/02/2008US20080241237 Taste-masked microparticles of hydroxyzine, cetirizine (hydrochloride), efletirizine, meclizine, buclizine or levocetirizine dihydrochloride coated with a taste-masking coating of a water insoluble polymer and an enteric polymer; orally disintegrating tablets; storage stability
10/02/2008US20080241212 Tyrosine-derived aromatic polyester sheet, film or mat of nanofibers optionally including anesthetics, antiinflammatories, microbiocides, leukotriene inhibitors, or antiscarring, antifibrotic, or antineoplastic agents, and that resists capsular contracture and adherence to the implant
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor
10/02/2008US20080241125 Muc1-ikb kinase complexes and their activities
10/02/2008US20080241124 Nucleotide sequences coding g-protein couple receptor for use in identifying modulators for prevention and treatment of inflammation, sarcoidosis and rheumatoid arthritis
10/02/2008US20080241112 Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008DE102007015824A1 Agent, useful for the treatment of udder mastitis in mammals, preferably dairy cattle and of breast mastitis in humans, comprises an aqueous solution of N-chlorotaurine or its salt, preferably sodium salts
10/02/2008CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008CA2681206A1 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/02/2008CA2679885A1 Aminomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
10/01/2008EP1975153A2 Protease inhibitors
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974739A1 Methods and compounds for modulating inflammatory processes
10/01/2008EP1974719A1 Conditioned medium and its uses
10/01/2008EP1973911A2 Azaindoles useful as inhibitors of janus kinases
10/01/2008EP1973901A1 Hydantoin derivatives for the treatment of inflammatory disorders
10/01/2008EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders
10/01/2008EP1973884A2 Novel heterocycles
10/01/2008EP1973547A1 Compounds having cytokine modulating properties
10/01/2008EP1973540A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
10/01/2008EP1565456B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008EP1212295B1 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
10/01/2008CN201123905Y Membrane tablet for lumbago
10/01/2008CN101277962A Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2
10/01/2008CN101277961A Tetrahydro-pyrrolizinone compounds as LFA-1 mediators
10/01/2008CN101277697A Dermatitis remedies
10/01/2008CN101274962A Antibodies against human IL-12
10/01/2008CN101274953A Method for extracting corosolic acid from plant
10/01/2008CN101274091A Compound formulation of capsules for curing cold and preparing technique
10/01/2008CN101274083A Compound formulation of capsules for curing dysmenorrheal, non-stopping menstruation and preparing technique
10/01/2008CN101274079A Dogskin plaster and technique of preparing the same
10/01/2008CN101274067A Medical ointment for activating blood circulation, removing stasis, dredging channels and collaterals, releasing swelling and relieving pain, and method for preparing the same
10/01/2008CN101274055A Medicament for fumigating rheumatic arthritis and rheumatoid arthritis
10/01/2008CN101274053A Quality control method of capsules for curing waist pain
10/01/2008CN101274048A Compound formulation of capsules for curing injuries from falls and preparing technique
10/01/2008CN101274034A Composition for relieving exterior syndrome, clearing heat and detoxicating, method for preparing the same, and quality control method
10/01/2008CN101274032A Chinese medicinal composition for curing erythromelalgia and method of preparing the same